DRUG · Mapped RxNorm record
Palbociclib
Normalized identity: palbociclibView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
NCT04360941
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Avelumab
Normalized identity: avelumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Locally Advanced Breast Cancerunresolved
Recurrent Breast Cancerunresolved
Metastatic Breast Cancerunresolved
Interventions
PalbociclibDRUG · verified · RxNorm: palbociclib
AvelumabDRUG · verified · RxNorm: avelumab
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04360941 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.